Education
About Us
Working with TipRanks
Follow Us
Evolutionary Genomics (FNAM)
:FNAM
FNAM Stock Chart & Stats
$0.45
-$0.45(-99.82%)
At close: 4:00 PM EDT
$0.45
-$0.45(-99.82%)
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Volume15.83K
Average Volume (3M)N/A
Market Cap
$1.33K
Enterprise ValueN/A
Total Cash (Recent Filing)$577.07K
Total Debt (Recent Filing)$3.74M
Price to Earnings (P/E)―
Beta-0.31
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding6,655,232
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)-2.87
Price to Sales (P/S)0.00
P/FCF Ratio-7.01
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
FNAM FAQ
What was Evolutionary Genomics’s price range in the past 12 months?
Currently, no data Available
What is Evolutionary Genomics’s market cap?
Evolutionary Genomics’s market cap is $1.33K.
When is Evolutionary Genomics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Evolutionary Genomics’s earnings last quarter?
Currently, no data Available
Is Evolutionary Genomics overvalued?
According to Wall Street analysts Evolutionary Genomics’s price is currently Overvalued.
Does Evolutionary Genomics pay dividends?
Evolutionary Genomics does not currently pay dividends.
What is Evolutionary Genomics’s EPS estimate?
Evolutionary Genomics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Evolutionary Genomics have?
Evolutionary Genomics has 6,655,232 shares outstanding.
What happened to Evolutionary Genomics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Evolutionary Genomics?
Currently, no hedge funds are holding shares in FNAM
Company Description
Evolutionary Genomics
Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. Evolutionary Genomics, Inc. was incorporated in 1990 and is based in Castle Rock, Colorado.
Technical Analysis
Salarius Pharmaceuticals
―
Quoin Pharmaceuticals
―
Processa Pharmaceuticals
―
GRI Bio
―
Protagenic Therapeutics
―